Zacks Investment Ideas Highlights: CF Industries Holdings, Inc. and Nutrien, Ltd

0

For immediate release

Chicago, IL – January 13, 2022 – Today Zacks Investment Ideas Presents Highlights Features: CF Industries Holdings, Inc. CF and Nutrien, Ltd. NTR.

How the strength of ETFs can guide investors to the best stocks

There has never been a better time for investors to take advantage of global market trends than now. Both bullish and bearish price trends exist in the global equity, currency and commodity markets. Exchange-traded funds (ETFs) are a great investment vehicle to take advantage of these price trends.

ETFs were first traded in 1993 and have exploded in popularity ever since. While they have many of the same benefits as mutual funds, one distinct difference is that ETFs generally don’t distribute capital gains to shareholders. The accounting and tax process for ETFs is therefore much simpler than for mutual funds that require investors to record distributions. In many cases, ETFs also offer cheaper expense ratios.

ETFs hold a pool of securities and are designed to track a particular index, sector, commodity or currency. There are thousands of ETFs that track the performance of various stock indices and sectors. Another distinct advantage of investing in ETFs is that by following specific ETFs, investors can more easily detect individual stocks that are outperforming the general market.

A good example in the current market environment is the VanEck Vectors Agribusiness ETF (MOO). This ETF is currently trading near an all-time high. MOO had been in a consolidation pattern since the second quarter of last year, as shown below. We had something of a fake breakout in early November, and MOO is knocking on the door again as it breaks that range. New highs are a sign of strength.

Our proprietary research here at Zacks indicates a low risk rating for the MOO ETF.

We will analyze two stocks which are both currently ranked #1 (Strong Buy) based on our proprietary Zacks Rank system. Both stocks saw positive earnings estimate revision activity. These two securities represent approximately 8% of the MOO’s total holdings.

The two stocks we’ll discuss below are part of the Zacks Fertilizers industry group, which ranks in the top 2% of 254 industries. We expect this industry group to outperform the market over the next three to six months. By focusing on stocks in the top industries ranked by Zacks, investors can significantly improve their likelihood of investing success.

CF Industries Holdings, Inc.

CF Industries Holdings is a global manufacturer and sells hydrogen and nitrogen products for clean energy, fertilizer and related industrial applications. World leader in the transformation of natural gas into nitrogenous products, CF is one of the largest distributors of nitrogenous fertilizers and other related products. CF Industries Holdings was founded in 1946 and is based in Deerfield, IL.

CF’s main products include anhydrous ammonia, granular urea and ammonium nitrate products. The company primarily serves independent fertilizer distributors, traders, wholesalers and industrial users. CF is well positioned to benefit from rising nitrogen demand in North America, driven by healthy corn acreage in the United States. A recovery in nitrogen prices will also boost the company’s results.

CF revenue in 2021 is expected to have increased by 143.54% to $3.58 compared to 2020. Revenue is expected to have increased by 55.01% to $6.39 billion. Even more impressive is the fact that analysts have increased their 2022 EPS estimates for FC by 27.84% over the past 60 days. Revenue is expected to increase 246.42% to $12.40 from 2021.

CF is trading at an attractive valuation (5.58 forward P/E) and is posting an average of +97.82% broken earnings over the past four quarters. CF stock outperformed the market last year with a return of 52.73%.

What the Zacks Model Reveals

The Zacks Earnings ESP (Expected Surprise Prediction) seeks to identify companies that have recently experienced positive earnings estimate revision activity. This proprietary technique has proven to be very useful in finding positive profit surprises. In fact, combining a No. 3 or higher Zacks ranking with a positive earnings ESP, stocks produced a positive surprise 70% of the time according to our 10-year backtest.

CF boasts a +20.03% earnings ESP and a Zacks #1 Strong Buy ranking, indicating a beatdown could be in the cards when the company reports on Feb. 16.and.

Nutrien, Ltd.

Nutrien Ltd. produces and sells fertilizers and related industrial and food products. NTR offers potash, nitrogen, phosphate and sulfate products. Based in Saskatoon, Canada, Nutrien also distributes crop nutrients, protection products and seeds to approximately 2,000 retail locations internationally.

NTR benefits from higher global demand for crop nutrients. Strong grower economies and rising crop prices are driving demand for fertilizers around the world. Higher selling prices should boost the company’s sales and margins. NTR is also poised to take advantage of acquisitions, particularly the acquisition of Tec Agro last year, which strengthened the company’s presence in the growing Brazilian agricultural market. Nutrien expects its total annual sales in Brazil to be around $500 million.

Revenue in 2021 is expected to have increased by 233.89% to $6.01. Last year’s revenue is expected to have risen 27.07% to $26.5 billion from 2020. Analysts also raised their 2022 EPS estimates by 10.94% over the past 60 days. The Zacks consensus estimate now stands at $8.82, which would represent growth of 46.86% from 2021.

NTR is trading at a forward P/E of 7.94 and benefits from an attractive price chart. The company recently reported quarterly EPS of $1.38 in November, a surprise +12.2% from consensus. NTR delivered a four-quarter average earnings surprise of +73.49%, supporting the stock’s 36.08% return over the past year.

Nutrien is scheduled for its next earnings announcement on February 16and. Both of these Zacks #1 Strong Buy stocks are expected to continue their strong runs through 2022.

Breakout biotech stocks with triple-digit profit potential

The biotechnology sector is expected to surpass $2.4 trillion by 2028, with scientists developing treatments for thousands of diseases. They are also finding ways to modify the human genome to literally erase our vulnerability to these diseases.

Zacks just came out Century of Biology: 7 biotech stocks to buy right now to help investors take advantage of 7 stocks poised to outperform. Recommendations from previous editions of this report produced gains of +205%, +258% and +477%. Stocks in this report could perform even better.

See these 7 game-changing actions now >>

Follow us on twitter: https://twitter.com/ZacksResearch

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including broker and investment adviser), which may engage in transactions involving the aforementioned securities for clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

https://www.zacks.com

Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for more information on the performance figures displayed in this press release.

Bitcoin, like the internet itself, could change everything

Blockchain and cryptocurrency have sparked one of the most exciting topics of discussion of a generation. Some call it the “Internet of Money” and predict that it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree that we are still in the early stages of this technology and as it develops, it will create several investment opportunities.

Zacks just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and other cryptocurrencies with far less volatility than buying them outright.

See 3 Crypto-Related Stocks Now >>

Click to get this free report

CF Industries Holdings, Inc. (CF): Free Inventory Analysis Report

Nutrien Ltd. (NTR): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Share.

Comments are closed.